| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1261 | 2020 |
| SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... Nature 587 (7833), 270-274, 2020 | 1210 | 2020 |
| COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ... Nature biotechnology 38 (8), 970-979, 2020 | 1000 | 2020 |
| Mapping the human genetic architecture of COVID-19 CHG Initiative Nature, 473-477, 2021 | 716* | 2021 |
| Estimating infectiousness throughout SARS-CoV-2 infection course TC Jones, G Biele, B Mühlemann, T Veith, J Schneider, ... Science 373 (6551), eabi5273, 2021 | 492 | 2021 |
| Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection CB Messner, V Demichev, D Wendisch, L Michalick, M White, A Freiwald, ... Cell systems 11 (1), 11-24. e4, 2020 | 467 | 2020 |
| Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... Jama 328 (16), 1604-1615, 2022 | 419 | 2022 |
| mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant H Gruell, K Vanshylla, P Tober-Lau, D Hillus, P Schommers, C Lehmann, ... Nature medicine 28 (3), 477-480, 2022 | 404 | 2022 |
| Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study D Hillus, T Schwarz, P Tober-Lau, K Vanshylla, H Hastor, C Thibeault, ... The Lancet Respiratory Medicine 9 (11), 1255-1265, 2021 | 347 | 2021 |
| A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 325 | 2020 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 311 | 2021 |
| Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination L Loyal, J Braun, L Henze, B Kruse, M Dingeldey, U Reimer, F Kern, ... Science 374 (6564), eabh1823, 2021 | 246 | 2021 |
| Ultra-fast proteomics with Scanning SWATH CB Messner, V Demichev, N Bloomfield, JSL Yu, M White, M Kreidl, ... Nature biotechnology 39 (7), 846-854, 2021 | 210 | 2021 |
| Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells M Witkowski, C Tizian, M Ferreira-Gomes, D Niemeyer, TC Jones, ... Nature 600 (7888), 295-301, 2021 | 169 | 2021 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 169 | 2021 |
| Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19 S Trump, S Lukassen, MS Anker, RL Chua, J Liebig, L Thürmann, ... Nature biotechnology 39 (6), 705-716, 2021 | 160 | 2021 |
| Adolescence as risk factor for adverse pregnancy outcome in Central Africa–a cross-sectional study F Kurth, S Belard, G Mombo-Ngoma, K Schuster, AA Adegnika, ... PloS one 5 (12), e14367, 2010 | 152 | 2010 |
| Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses M Ugolini, J Gerhard, S Burkert, KJ Jensen, P Georg, F Ebner, SM Volkers, ... Nature immunology 19 (4), 386-396, 2018 | 151 | 2018 |
| Complement activation induces excessive T cell cytotoxicity in severe COVID-19 P Georg, R Astaburuaga-García, L Bonaguro, S Brumhard, L Michalick, ... Cell 185 (3), 493-512. e25, 2022 | 148 | 2022 |
| A time-resolved proteomic and prognostic map of COVID-19 V Demichev, P Tober-Lau, O Lemke, T Nazarenko, C Thibeault, ... Cell systems 12 (8), 780-794. e7, 2021 | 141 | 2021 |
Peter G. KremsnerProfessor for Tropical Medicine, Travel Medicine and Parasitology, University of TübingenVerified email at uni-tuebingen.de
